How to Help Your Patients Find Uzedy in Stock: A Provider's Guide

Prescribing Uzedy (risperidone extended-release injectable suspension) is one thing. Getting it into the hands — or rather, under the skin — of your patient is another. This guide is a practical, step-by-step resource for psychiatrists, nurse practitioners, physician assistants, and clinic staff who want to ensure smooth access to Uzedy for their patients in 2026.

Step 1: Establish Oral Risperidone Tolerability Before the First Injection

Per the FDA prescribing information, Uzedy should only be initiated in patients who have established tolerability with oral risperidone. Before placing any specialty pharmacy orders or starting the PA process, confirm that the patient has had a documented trial of oral risperidone without unacceptable adverse events. Uzedy can be initiated the day after the last oral risperidone dose — no oral overlap or loading dose is needed, which is one of its clinical advantages.

Step 2: Engage Teva Total Support™ Immediately at Prescribing

The single most impactful step is early engagement with Teva Total Support™ (1-800-887-8100, Monday–Friday, 9 AM–8 PM ET). Do not wait until the patient's first injection appointment is scheduled. Engage the hub at the time of the prescribing decision. Teva Total Support provides:

Benefits investigation: Confirms the patient's medical and pharmacy insurance coverage for Uzedy, including copay tier and prior auth requirements.

Prior authorization support: Teva Total Support can initiate the PA process and provide clinical documentation templates to support approval.

Specialty pharmacy connection: They will identify specialty pharmacies in your area that stock Uzedy and can facilitate the dispensing arrangement.

Savings enrollment: Enroll eligible commercially insured patients in the Uzedy savings offer (potentially $0 per dose) and identify PAPs for uninsured or underinsured patients.

Step 3: Navigate Prior Authorization Effectively

Uzedy is billed through the patient's medical benefit (typically under J-code or NOC billing for specialty injectables), not the pharmacy benefit. This is important for front-office and billing staff to understand. PA criteria commonly include:

Confirmed diagnosis of schizophrenia or bipolar I disorder (ICD-10 documentation)

Documentation of prior oral risperidone trial and tolerability

Clinical justification for LAI over oral therapy (e.g., adherence history, relapse risk)

Prescriber specialty — some plans require prescribing by or in consultation with a psychiatrist

If the PA is denied, request a peer-to-peer review. Uzedy's unique clinical attributes — rapid therapeutic onset (6–24 hours) without oral overlap, flexible dosing intervals including q2M, and subcutaneous vs. IM route — can support the argument for medical necessity over other available LAI options.

Step 4: Set Up In-Clinic Dispensing

The smoothest patient experience for Uzedy is in-clinic administration: the medication is ordered from a specialty pharmacy to your clinic, and your staff administers it at the patient's appointment. This eliminates the pharmacy pickup burden entirely. To set this up:

Establish an account with one or more specialty pharmacies (Walgreens Specialty, CVS Specialty, Accredo, Optum Specialty).

Ensure your clinic has appropriate storage capabilities (Uzedy requires specific storage conditions; check the package insert for temperature requirements).

Train nursing or MA staff on subcutaneous administration technique, including the Z-pinch technique recommended for Uzedy.

FQHCs and CMHCs may be eligible for 340B drug pricing for Uzedy, which can substantially reduce per-dose costs for qualifying patients.

Step 5: Use medfinder for Patients Who Need External Pharmacy Access

For patients who must receive Uzedy at an external pharmacy or clinic, medfinder for providers offers a practical solution. medfinder calls pharmacies on the patient's behalf to confirm which ones can fill the specific Uzedy dose, then texts the patient the results. This tool can save your front office significant time that is often spent on the phone confirming specialty pharmacy stock.

Step 6: Have a Clinical Bridge Plan Ready

Even with proactive planning, a patient may occasionally miss an Uzedy injection due to pharmacy or scheduling issues. Prepare a clear bridge plan:

For delays of 1–2 weeks: attempt to reschedule the injection at your clinic or an alternative administration site.

For delays greater than 2 weeks: consider oral risperidone bridge at an appropriate dose while the injection is being sourced.

For prolonged delays: reassess whether a different LAI with broader stocking is more appropriate for this patient's ongoing care.

The Bottom Line for Providers

Uzedy access is manageable with the right infrastructure in place. The key is proactive planning: early hub engagement, PA anticipation, in-clinic administration setup, and patient support tools like medfinder. For guidance on the cost and savings side, see our related guide: How to Help Your Patients Save Money on Uzedy: A Provider's Guide.